DNA vaccine against human papillomavirus type 16: Modifications of the E6 oncogene

Vaccine

Volumn 28, Issue 6, 2010, Pages 1506-1513

  Poláková, Ingrid ^a   Pokorná, Dana ^a   Dušková, Martina ^a   Šmahel, Michal ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

DNA vaccine; E6 oncogene; Gene gun; Human papillomavirus; Immunogenicity

Indexed keywords

BETA GLUCURONIDASE; DNA VACCINE; EPITOPE; PROTEIN E6; PROTEIN P53;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; CARCINOGENICITY; CONTROLLED STUDY; DNA IMMUNIZATION; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE FUSION; GENE GUN; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOGENICITY; INTRON; MOUSE; MUTAGENESIS; NONHUMAN; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CYTOKINES; ESCHERICHIA COLI PROTEINS; FEMALE; GENE EXPRESSION; GLUCURONIDASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTRONS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; POINT MUTATION; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; VACCINES, DNA;

EID: 75249086933     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.069     Document Type: Article

References (29)

1. Cutts F.T., Franceschi S., Goldie S., Castellsague X., de Sanjose S., Garnett G., et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 85 9 (2007) 719-726
2. Roden R.B., Monie A., and Wu T.C. Opportunities to improve the prevention and treatment of cervical cancer. Curr Mol Med 7 5 (2007) 490-503
3. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 5 (2002) 342-350
4. Rice J., Ottensmeier C.H., and Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8 2 (2008) 108-120
5. Leifert J.A., Rodriguez-Carreno M.P., Rodriguez F., and Whitton J.L. Targeting plasmid-encoded proteins to the antigen presentation pathways. Immunol Rev 199 (2004) 40-53
6. Smahel M., Sima P., Ludvikova V., and Vonka V. Modified HPV16 E7 genes as DNA vaccine against E7-containing oncogenic cells. Virology 281 2 (2001) 231-238
7. Smahel M., Sima P., Ludvikova V., Marinov I., Pokorna D., and Vonka V. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. Vaccine 21 11-12 (2003) 1125-1136
8. Smahel M., Pokorna D., Mackova J., and Vlasak J. Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli beta-glucuronidase. J Gene Med 6 10 (2004) 1092-1101
9. Pokorna D., Mackova J., Duskova M., Rittich S., Ludvikova V., and Smahel M. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect. J Gene Med 7 6 (2005) 696-707
10. Khammanivong V., Liu X.S., Liu W.J., Rodda S.J., Leggatt G.R., Tindle R.W., et al. Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunol Cell Biol 81 1 (2003) 1-7
11. Welters M.J., de Jong A., van den Eeden S.J., van der Hulst J.M., Kwappenberg K.M., Hassane S., et al. Frequent display of human papillomavirus type 16 E6-specific memory T-Helper cells in the healthy population as witness of previous viral encounter. Cancer Res 63 3 (2003) 636-641
12. de Jong A., van Poelgeest M.I., van der Hulst J.M., Drijfhout J.W., Fleuren G.J., Melief C.J., et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 64 15 (2004) 5449-5455
13. Wise-Draper T.M., and Wells S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 13 (2008) 1003-1017
14. Dalal S., Gao Q., Androphy E.J., and Band V. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol 70 2 (1996) 683-688
15. Liu Y., Chen J.J., Gao Q., Dalal S., Hong Y., Mansur C.P., et al. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol 73 9 (1999) 7297-7307
16. Nguyen M., Song S., Liem A., Androphy E., Liu Y., and Lambert P.F. A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. J Virol 76 24 (2002) 13039-13048
17. Smotkin D., Prokoph H., and Wettstein F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol 63 3 (1989) 1441-1447
18. Cornelissen M.T., Smits H.L., Briet M.A., van den Tweel J.G., Struyk A.P., van der N.J., et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol 71 Pt 5 (1990) 1243-1246
19. Griep A.E., Herber R., Jeon S., Lohse J.K., Dubielzig R.R., and Lambert P.F. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J Virol 67 3 (1993) 1373-1384
20. DuBridge R.B., Tang P., Hsia H.C., Leong P.M., Miller J.H., and Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7 1 (1987) 379-387
21. Lin K.Y., Guarnieri F.G., Staveley-O'Carroll K.F., Levitsky H.I., August J.T., Pardoll D.M., et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 56 1 (1996) 21-26
22. Fogh J., Fogh J.M., and Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59 1 (1977) 221-226
23. Smahel M., Polakova I., Pokorna D., Ludvikova V., Duskova M., and Vlasak J. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein. Int J Oncol 33 1 (2008) 93-101
24. Zolotukhin S., Potter M., Hauswirth W.W., Guy J., and Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70 7 (1996) 4646-4654
25. Chen C.A., and Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6 7 (1988) 632-638
26. Peng S., Ji H., Trimble C., He L., Tsai Y.C., Yeatermeyer J., et al. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. J Virol 78 16 (2004) 8468-8476
27. Howie H.L., Katzenellenbogen R.A., and Galloway D.A. Papillomavirus E6 proteins. Virology 384 2 (2009) 324-334
28. Shai A., Brake T., Somoza C., and Lambert P.F. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 67 4 (2007) 1626-1635
29. Nomine Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckere F., et al. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell 21 5 (2006) 665-678